Hemodynamic effects of naloxone on hemorrhagic shock in the beagle.
Naloxone reverses the hypotension in various types of hemorrhagic shock models. What has yet to be firmly established is the mechanism by which naloxone reverses the hypotension. In a canine hemorrhagic shock model, impedance cardiography and invasive methods were used to measure various cardiovascular parameters. All dogs (beagles, 10-15 kg) were bled to and maintained at a mean arterial blood pressure (MAP) of 60 mmHg for 90 min and were then given either naloxone (2 mg/kg; n = 6) or an equivalent volume of saline (n = 6) intravenously (IV). After another 90 min observation period, the shed blood was reinfused. No significant differences in the preshock and shock cardiodynamics were noted between the naloxone and the control animals. During the treatment period, MAP was significantly increased in the naloxone group. There was no increase in cardiac output (CO), stroke volume (SV), end diastolic volume (EDV), dP/dt max, dP/dt/P, or HI (the impedance contractility index) over control animals. The most significant parameter improvement was total peripheral resistance (TPR). The data suggest that naloxone in this hemorrhagic shock model improves hemodynamics primarily by increasing vascular resistance.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009270:Naloxone / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000187:drug effects; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D014655:Vascular Resistance / Q000187:drug effects
D009270:Naloxone